Definitive Contract 75F40122C00121
Award Date
9/27/22
Potential Completion Date
9/29/25
Potential Value
$494K
Federal Agency
Food and Drug Administration
Awardee
Drexel University
Ultimate Awardee
Not listed
NAICS Category
611310 - Colleges, Universities, and Professional Schools
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Philadelphia, PA 19104, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
165
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm-fixed-price purchase order contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to Drexel University, a private university, for the construction of a database Bio-Pharmaceutics Classification System. The contract has a ceiling value of $219,988.00 and a completion date of December 14, 2025. Drexel University has extensive experience in conducting advanced scientific research and providing educational services to federal agencies, including the Department...
This federal contract awarded to Drexel University by the Food and Drug Administration (FDA) is for immunopathology analysis of patient tissue samples from cardiovascular and/or orthopedic device implants. The $299,778.10 firm-fixed price contract has a period of performance running from September 2022 through March 2024. There is no set-aside designation used for this award. The original solicitation sought offerors with experience in similar tissue sample analysis to complete tasks such as...
The U.S. Food and Drug Administration (FDA) awarded a $696,359 firm-fixed-price contract to Duke University's Office of Research Administration Division to conduct research and development activities in support of regulatory science and innovation. The contract, which does not have a set-aside designation, originated from a Broad Agency Announcement (BAA) that solicits advanced proposals across nine key areas to advance scientific knowledge in support of the FDA's mission to protect public...
The Food and Drug Administration (FDA) awarded a $499,990 firm fixed price contract to Drexel University, a private research university, to conduct a study on how medical implantation alters local and/or systemic immune response relative to implanted metal-alloy devices. Drexel University will be the prime contractor, with Clemson University serving as a major subcontractor to analyze the effects of cobalt alloy implants on local tissue and distant organs. The contract has no set-aside...
This is a definitive contract awarded by the Food and Drug Administration (FDA) to Duke University in the amount of $1,046,733.02. The contract is for the "USE OF ELECTRONIC HEALTH RECORDS AS SOURCE DATA FOR CLINICAL RESEARCH" and has an ultimate completion date of December 28, 2020. The contract has a cost-no-fee pricing type and was not set aside for any socioeconomic program. Duke University, through its Office of Research Administration Division, is the prime contractor on this...
This is a firm fixed-price purchase order issued by the National Cancer Institute (NCI), a civilian agency of the U.S. government, to Drexel University, a private research university, for a FELLOWSHIP PROGRAM FEE. The award is valued at $16,400.00 with a performance period ending on June 30, 2025. The contract does not have a set-aside designation. Drexel University has a long history of serving as both a prime contractor and subcontractor on research and development initiatives funded by...
This federal contract award, valued at $699,087.00, was issued by the Food and Drug Administration (FDA) to Duke University's Office of Research Administration Division. The contract is a definitive Firm Fixed Price contract with a period of performance through March 12, 2028. It was awarded under a Broad Agency Announcement (BAA) that solicits research and development proposals to support the FDA's regulatory science and innovation agenda. Duke University, a leading academic research...
This is a $1,038,888.40 definitive contract awarded by the Food and Drug Administration (FDA) to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The contract is for instructor-led training on pharmacoepidemiology, which involves the study of the utilization and effects of drugs in large numbers of people. The contract has a period of performance through March 6, 2027. It is a firm fixed-price contract and does not have a...
This is a $3,526,785.00 definitive, firm fixed-price contract awarded by the Food and Drug Administration (FDA) to the Regents of the University of Michigan, doing business as the University of Michigan, for Prediction of In Vivo Performance Analysis Services. The contract has no set-aside designation. The University of Michigan is providing a range of research and development services under this contract, including developing high-performance computational models to simulate small intestine...
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to the Universitat ST. Gallen, doing business as Hochschule FÜR Wirtschafts-, Rechts- UND Sozialwissenschaften (Hsg), an educational institution. The contract is a Firm Fixed Price definitive contract with a potential value of $764,418.19 and a completion date of September 29, 2023. The contract was awarded under the FDA's Broad Agency Announcement (BAA) for Advanced Regulatory...